Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs operate by mimicking the natural actions of GLP-1, a hormone released by the gut https://socialmediainuk.com/story25039117/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes